An ALPK3 truncation variant causing autosomal dominant hypertrophic cardiomyopathy is partially rescued by mavacamten.
Leinhos L. et al, (2025), Sci Rep, 15
Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy.
Tadros R. et al, (2025), Nat Genet, 57, 530 - 538
Evaluation of polygenic scores for hypertrophic cardiomyopathy in the general population and across clinical settings.
Zheng SL. et al, (2025), Nat Genet
Genetic therapies for cardiomyopathy: survey of attitudes of the patient community for the CureHeart project.
Ormondroyd E. et al, (2024), Eur J Hum Genet, 32, 1045 - 1052
Secondary (additional) findings from the 100,000 Genomes Project: Disease manifestation, health care outcomes, and costs of disclosure.
Nolan J. et al, (2024), Genet Med, 26
Additional findings from the 100,000 Genomes Project: a qualitative study of recipient perspectives.
Nolan JJ. et al, (2024), Genet Med
Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases.
Pagnamenta AT. et al, (2023), Genome Med, 15
The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findings.
McGurk KA. et al, (2023), Am J Hum Genet, 110, 1482 - 1495
Direct-to-consumer genetic tests providing health risk information: A systematic review of consequences for consumers and health services.
Nolan JJ. and Ormondroyd E., (2023), Clin Genet
Direct‐to‐consumer genetic tests providing health risk information: A systematic review of consequences for consumers and health services
Nolan J. and ORMONDROYD E., (2023), Clinical Genetics: an international journal of genetics and molecular medicine
A practical checklist for return of results from genomic research in the European context
Vears DF. et al, (2023), European Journal of Human Genetics
Large scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy.
Tadros R. et al, (2023), medRxiv
Public and patient involvement in research to support genome services development in the UK
Hunter A. et al, (2023), Journal of Translational Genetics and Genomics, 7, 17 - 26
The Genetic Basis of Primary Cardiomyopathies in Childhood: Implications for Clinical Genetic Testing.
Thomson KL. and Ormondroyd E., (2022), Circ Genom Precis Med, 15
Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy.
Mahmod M. et al, (2022), J Cardiovasc Magn Reson, 24
Genomic sequencing in oncology: Considerations for integration in routine cancer care
Rahman B. et al, (2022), European Journal of Cancer Care
Provocation Testing and Therapeutic Response in a Newly Described Channelopathy: RyR2 Calcium Release Deficiency Syndrome.
Ormerod JOM. et al, (2022), Circ Genom Precis Med, 15